Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis (Q46084628)

19 December 2017

title

Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis (English)

1 reference

19 December 2017

1 reference

5

Gordon J Freeman

1 reference

19 December 2017

Arlene Sharpe

4

object named as

Arlene H Sharpe

1 reference

19 December 2017

author name string

Ling Chen

1

1 reference

19 December 2017

Vicky Pai

2

1 reference

19 December 2017

Ralph Levinson

3

1 reference

19 December 2017

Jonathan Braun

6

1 reference

19 December 2017

Lynn K Gordon

7

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

Ocular Immunology and Inflammation

published in

1 reference

19 December 2017

volume

17

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

47-55

1 reference

19 December 2017

Ocular autoimmunity: the price of privilege?

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Long-term Follow-up of Intermediate Uveitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

The role of T cells in autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

The PD-1-PD-L pathway in immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Immunology of B7-H1 and its roles in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Neuronal plasticity and cellular immunity: shared molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

Functional requirement for class I MHC in CNS development and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802491884

10.1080/09273940802491884

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19294574

1 reference

19 December 2017